| 289 |
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence |
Department of Pathology |
2023 |
| 290 |
Targeted optimum care approach for osteoporotic fragility fractures: tailored strategy based on risk stratification to reduce incidents of falls—an initiative by the Egyptian Academy of bone health based on the FLS national register |
Department of Rheumatology ,Rehabilitation & physical medicine |
2023 |
| 291 |
Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate |
Department of Forensic Medicine and Clinical Toxicology |
2023 |
| 292 |
Correlation between metabolic uptake of F-18-FDGPET/computed tomography and thyroglobulin level in differentiated thyroid cancer patients with suspected recurrence |
Department of Clinical Oncology and Nuclear Medicine |
2023 |
| 293 |
Correlation of Fecal Calprotectin Level with Mayo Endoscopic Score and Disease Extent Assessed by Magnetic Resonance Enterography in Ulcerative Colitis Patients |
Department of Diagnostic Radiology |
2023 |
| 294 |
Acetylated Oligopeptide and N‑acetyl cysteine Protected Against Oxidative Stress, Inflammation, Testicular‑Blood Barrier Damage, and Testicular Cell Death in Iron‑Overload Rat Model |
Department of Biochemistry |
2023 |
| 295 |
A randomized comparative study of flexible ureterorenoscopy versus mini-percutaneous nephrolithotomyfor treatment of renal stones 2 cm or less |
Department of Urology |
2023 |
| 296 |
Serum and synovial fluid 14-3-3η protein in patients with primary knee osteoarthritis compared with rheumatoid arthritis: relation to functional status and radiographic damage |
Department of Rheumatology ,Rehabilitation & physical medicine |
2023 |
| 297 |
The anti-inflammatory effects of atorvastatin upon the outcome of traumatic brain injury patients: A randomized-controlled double-blind clinical trial |
Department of Anesthesia and Intensive Care |
2023 |
Do you have any questions? 
